David J. Earp
Non-Executive Director
Health Care
Sienna Cancer Diagnostics
Australia
Biography
David J. Earp, BSc (Hons), J.D., Ph.D. joined the Sienna Board in December 2012. David was a partner in an intellectual property law firm, advising life science clients, prior to taking senior roles in a number of biotechnology companies. From 1999 until 2012, David served in various roles at Geron Corporation (Menlo Park, California), a NASDAQ listed company, including chief patent counsel, chief legal officer and senior vice president of corporate transactions. From 2005 to 2010, David was a board member of TA Therapeutics Ltd. (Hong Kong, PRC). He served on the board of ViaGen Corporation (Austin, Texas) from 2008 – 2012, including as executive chairman from 2010 – 2012 when the company was acquired in a trade sale. He is presently the president, CEO and a director of Circle Pharma, an early stage biotechnology company located in San Francisco, California. David holds a BSC with First Class Honours from Leeds University (UK), a PhD in biochemistry from Cambridge University (UK) and a JD from Lewis and Clark Northwestern School of Law (Portland, Oregon).
Research Interest
Business Growth
